[Medico-economic aspects of the management of perennial allergic rhinitis in general medicine].
A cross sectorial epidemiologic study was conducted in daily medical practice on the cost of perannual rhinitis. This study on 2033 patients shows per consultation the following costs. Medical fees: 130 +/- 45 francs, pharmaceutical expenses: 141 +/- 59 francs, biological and imaging: 109 +/- 174 francs. The indirect costs link to the absent days are evaluated at 776 francs. This rhinitis costs 1156 francs or 380 francs according the fact that the patient stops working or not. The extrapolation of these results to the french population shows 3.42 billions francs for the direct costs and 6 billions for the indirect costs. By comparison to this total amount, medical and pharmaceutical expenses represent only 11.7% and 12.7%.
Dessi
P
P
Service O.R.L., Hôpital de la Timone-CHRU, Marseille.
Allaert
F A
FA
Urbinelli
R
R
Verrière
J L
JL
D000041:Absenteeism; D000293:Adolescent; D000328:Adult; D018926:Anti-Allergic Agents / Q000191:economics / Q000627:therapeutic use; D003430:Cross-Sectional Studies; D016527:Drug Costs; D005194:Family Practice / Q000191:economics*; D005249:Fees and Charges; D005260:Female; D005602:France / Q000453:epidemiology; D017048:Health Care Costs; D006801:Humans; D008297:Male; D008875:Middle Aged; D011933:Reagent Kits, Diagnostic / Q000191:economics; D012221:Rhinitis, Allergic, Perennial / Q000191:economics* / Q000453:epidemiology / Q000628:therapy
D018926:Anti-Allergic Agents; D011933:Reagent Kits, Diagnostic